Related Experiment Videos
Necrotizing pneumonia in children.
M Hacimustafaoglu1, S Celebi, H Sarimehmet
1Department of Paediatrics and Paediatric Infectious Diseases, Uludag University Medical Faculty, Bursa, Turkey. mkemal@uludag.edu.tr
Acta Paediatrica (Oslo, Norway : 1992)
|September 24, 2004
Summary
Necrotizing pneumonia (NP) in children presents with longer symptoms and higher inflammatory markers than parapneumonic effusions (PPE) or control pneumonia (CP). NP patients experienced more complications, longer hospital stays, and higher treatment costs, necessitating surgical intervention in many cases.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Radiology
Background:
- Necrotizing pneumonia (NP) is a severe form of pneumonia characterized by lung tissue destruction.
- Distinguishing NP from other pneumonia types like parapneumonic effusions (PPE) and control pneumonia (CP) is crucial for appropriate management.
- Clinical and laboratory features, along with treatment outcomes, require detailed investigation.
Purpose of the Study:
- To investigate and compare the clinical features and outcomes of necrotizing pneumonia (NP) with parapneumonic effusions (PPE) and severe control pneumonia (CP) in children.
- To identify key diagnostic markers and prognostic indicators for NP.
Main Methods:
- A comparative study involving 36 patients with NP, 36 with PPE, and 36 with CP.
- Diagnosis of NP was confirmed using computerized tomography (CT).
- Clinical data, laboratory results (WBC, ESR, CRP, AST), hospitalization duration, febrile days, CRP normalization time, treatment costs, and complications were analyzed.
Main Results:
- Patients with NP exhibited significantly longer symptom duration (11.9 days) compared to PPE (9.2 days) and CP (6 days).
- NP group showed significantly higher WBC, ESR, CRP, and AST levels, longer hospitalization (26 days), more febrile days (8 days), and prolonged CRP normalization (14 days).
- NP was associated with higher treatment costs ($3476) and a higher rate of complications, including parapneumonic effusions (94%) and bronchopleural fistula (55%), requiring surgery in 66% of cases.
Conclusions:
- Necrotizing pneumonia is a severe condition in children with distinct clinical and laboratory profiles.
- The high rate of complications and need for surgical intervention in NP underscore its severity.
- Prompt diagnosis and management are essential for improving outcomes in pediatric NP.